Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Coop

Showing results (21-30 of 95) with videos related to

Pageof 10
Sort By:
The Journal of Physical Chemistry. B|November 2, 2016
Conformational Heterogeneity of Intracellular Loop 3 of the μ-opioid G-protein Coupled ReceptorJing Huang, Sirish Kaushik Lakkaraju, Andrew Coop, et al.
Molecular Pharmaceutics|June 6, 2006
Influence of charge and steric bulk in the C-24 region on the interaction of bile acids with human apical sodium-dependent bile acid transporterAnand Balakrishnan, Stephen A Wring, Andrew Coop, et al.
Bioorganic & Medicinal Chemistry Letters|May 24, 2008
Opioids and efflux transporters. Part 3: P-glycoprotein substrate activity of 3-hydroxyl addition to meperidine analogsSusan L Mercer, Christopher W Cunningham, Natalie D Eddington, et al.
European Journal of Pharmacology|June 27, 2006
N-[2-(m-methoxyphenyl)ethyl]-N-ethyl-2-(1-pyrrolidinyl)ethylamine (UMB 116) is a novel antagonist for cocaine-induced effectsAnTawan Daniels, Erika Ayala, Weibin Chen, et al.
Psychopharmacology|February 28, 2002
Effects of the putative antagonist NCS382 on the behavioral pharmacological actions of gammahydroxybutyrate in miceCharles D Cook, Mario D Aceto, Andrew Coop, et al.
Journal of Pharmaceutical Sciences|April 17, 2009
Differential involvement of P-glycoprotein (ABCB1) in permeability, tissue distribution, and antinociceptive activity of methadone, buprenorphine, and diprenorphine: in vitro and in vivo evaluationHazem E Hassan, Alan L Myers, Andrew Coop, et al.
Behavioural Pharmacology|March 31, 2006
Discriminative stimulus effects of flumazenil: perceptual masking by baclofen, and lack of substitution with gamma-hydroxybutyrate and its precursors 1,4-butanediol and gamma-butyrolactoneWouter Koek, Lawrence P Carter, Huifang Wu, et al.
Pharmacology, Biochemistry, and Behavior|January 24, 2007
Effects of UMB24 and (+/-)-SM 21, putative sigma2-preferring antagonists, on behavioral toxic and stimulant effects of cocaine in miceRae R Matsumoto, Buddy Pouw, Aisha L Mack, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 30, 2008
Attenuation of methamphetamine-induced effects through the antagonism of sigma (sigma) receptors: Evidence from in vivo and in vitro studiesRae R Matsumoto, Jamaluddin Shaikh, Lisa L Wilson, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 7, 2005
Discriminative stimulus effects of gamma-hydroxybutyrate: role of training doseWouter Koek, Weibin Chen, Susan L Mercer, et al.
Pageof 10

Showing results (21-30 of 95) with videos related to

Sort By:
Pageof 10
The Journal of Physical Chemistry. B|November 2, 2016
Conformational Heterogeneity of Intracellular Loop 3 of the μ-opioid G-protein Coupled ReceptorJing Huang, Sirish Kaushik Lakkaraju, Andrew Coop, et al.
Molecular Pharmaceutics|June 6, 2006
Influence of charge and steric bulk in the C-24 region on the interaction of bile acids with human apical sodium-dependent bile acid transporterAnand Balakrishnan, Stephen A Wring, Andrew Coop, et al.
Bioorganic & Medicinal Chemistry Letters|May 24, 2008
Opioids and efflux transporters. Part 3: P-glycoprotein substrate activity of 3-hydroxyl addition to meperidine analogsSusan L Mercer, Christopher W Cunningham, Natalie D Eddington, et al.
European Journal of Pharmacology|June 27, 2006
N-[2-(m-methoxyphenyl)ethyl]-N-ethyl-2-(1-pyrrolidinyl)ethylamine (UMB 116) is a novel antagonist for cocaine-induced effectsAnTawan Daniels, Erika Ayala, Weibin Chen, et al.
Psychopharmacology|February 28, 2002
Effects of the putative antagonist NCS382 on the behavioral pharmacological actions of gammahydroxybutyrate in miceCharles D Cook, Mario D Aceto, Andrew Coop, et al.
Journal of Pharmaceutical Sciences|April 17, 2009
Differential involvement of P-glycoprotein (ABCB1) in permeability, tissue distribution, and antinociceptive activity of methadone, buprenorphine, and diprenorphine: in vitro and in vivo evaluationHazem E Hassan, Alan L Myers, Andrew Coop, et al.
Behavioural Pharmacology|March 31, 2006
Discriminative stimulus effects of flumazenil: perceptual masking by baclofen, and lack of substitution with gamma-hydroxybutyrate and its precursors 1,4-butanediol and gamma-butyrolactoneWouter Koek, Lawrence P Carter, Huifang Wu, et al.
Pharmacology, Biochemistry, and Behavior|January 24, 2007
Effects of UMB24 and (+/-)-SM 21, putative sigma2-preferring antagonists, on behavioral toxic and stimulant effects of cocaine in miceRae R Matsumoto, Buddy Pouw, Aisha L Mack, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 30, 2008
Attenuation of methamphetamine-induced effects through the antagonism of sigma (sigma) receptors: Evidence from in vivo and in vitro studiesRae R Matsumoto, Jamaluddin Shaikh, Lisa L Wilson, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 7, 2005
Discriminative stimulus effects of gamma-hydroxybutyrate: role of training doseWouter Koek, Weibin Chen, Susan L Mercer, et al.
Pageof 10